XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholder's Equity / (Deficit) - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Revision of Prior Period, Adjustment [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Previously Reported [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Previously Restated [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Revision of Prior Period, Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Member]
Previously Reported [Member]
Beginning balance at Dec. 31, 2019 $ (12,692) $ (165,670) $ 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   $ 195,599 $ 42,621 $ 152,978 $ (208,218) $ (208,218) $ (73) $ (73)
Beginning balance, shares at Dec. 31, 2019       7,695,112 (7,695,112) 2,786,800 234,387 2,552,413                
Issuance of common stock warrants 7,212                 7,212            
Stock-based compensation 5,443                 5,443            
Shares issued upon exercise of options $ 34                 34            
Shares issued upon exercise of options, shares 1,549         1,549                    
Other comprehensive gain (loss) $ 12                           12  
Net loss (35,835)                       (35,835)      
Ending balance at Dec. 31, 2020 (35,826) (188,804) 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   208,288 55,310 152,978 (244,053) (244,053) (61) (61)
Ending balance, shares at Dec. 31, 2020       7,695,112 (7,695,112) 2,788,351 234,785 2,553,566 2,788,349              
Issuance of common stock warrants 21,971                 21,971            
Issuance of Restricted Stock Awards ("RSAs") 563                 563            
Issuance of Restricted Stock Awards ("RSAs"), shares           58,199                    
Stock-based compensation 1,017                 1,017            
Shares issued upon exercise of options 74                 74            
Shares issued upon exercise of options, shares           3,878                    
Other comprehensive gain (loss) 5                           5  
Net loss (14,714)                       (14,714)      
Ending balance at Mar. 31, 2021 (26,910)         $ 0       231,913     (258,767)   (56)  
Ending balance, shares at Mar. 31, 2021           2,850,428                    
Beginning balance at Dec. 31, 2020 (35,826) (188,804) 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   208,288 55,310 152,978 (244,053) (244,053) (61) (61)
Beginning balance, shares at Dec. 31, 2020       7,695,112 (7,695,112) 2,788,351 234,785 2,553,566 2,788,349              
Net loss (35,181)                              
Ending balance at Jun. 30, 2021 (41,664)         $ 0       237,637     (279,234)   (67)  
Ending balance, shares at Jun. 30, 2021           2,850,428                    
Beginning balance at Dec. 31, 2020 (35,826) (188,804) 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   208,288 55,310 152,978 (244,053) (244,053) (61) (61)
Beginning balance, shares at Dec. 31, 2020       7,695,112 (7,695,112) 2,788,351 234,785 2,553,566 2,788,349              
Issuance of common stock warrants 21,971                 21,971            
Issuance of Restricted Stock Awards ("RSAs") 7,905         $ 0       7,905            
Issuance of Restricted Stock Awards ("RSAs"), shares           58,199                    
Stock-based compensation 4,067                 4,067            
Shares issued upon exercise of options $ 74                 74            
Shares issued upon exercise of options, shares 3,878         3,878                    
Shares issued upon exercise of common stock warrants, shares           450                    
Net loss $ (63,544)                       (63,544)      
Ending balance at Dec. 31, 2021 (65,353) (218,331) 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   242,305 89,327 152,978 (307,597) (307,597) (61) (61)
Ending balance, shares at Dec. 31, 2021       7,695,112 (7,695,112) 2,850,876 250,898 2,599,978                
Beginning balance at Mar. 31, 2021 (26,910)         $ 0       231,913     (258,767)   (56)  
Beginning balance, shares at Mar. 31, 2021           2,850,428                    
Stock-based compensation 1,065                 1,065            
Other comprehensive gain (loss) (11)                           (11)  
Vesting of RSAs 4,659                 4,659            
Net loss (20,467)                       (20,467)      
Ending balance at Jun. 30, 2021 (41,664)         $ 0       237,637     (279,234)   (67)  
Ending balance, shares at Jun. 30, 2021           2,850,428                    
Beginning balance at Dec. 31, 2021 (65,353) (218,331) 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   242,305 89,327 152,978 (307,597) (307,597) (61) (61)
Beginning balance, shares at Dec. 31, 2021       7,695,112 (7,695,112) 2,850,876 250,898 2,599,978                
Conversion of 2023 Notes into common stock 101,978         $ 0       101,978            
Conversion of 2023 Notes into common stock, Shares           723,223                    
Issuance of common stock upon the reverse capitalization, net of offering costs (9,150)         $ 0       (9,150)            
Issuance of common stock upon the reverse capitalization, net of offering costs, Shares           411,610                    
Offering cost in connection with Business Combination and PIPE financing (12,450)                 (12,450)            
Issuance of PIPE shares 36,950                 36,950            
Stock Issued During Period, PIPE Shares, New Issues           184,750                    
Subsequent issuance of shares for offering costs incurred in connection with Business Combination and PIPE financing 9,531         $ 0       9,531            
Subsequent issuance of shares for offering costs incurred in connection with Business Combination and PIPE financing, shares           240,182                    
Issuance of common stock upon vesting of RSUs 0         $ 0                    
Issuance of common stock upon vesting of RSUs, shares           358,776                    
Issuance of common stock warrants 17,602                 17,602            
Stock-based compensation 51,561                 51,561            
Shares issued upon exercise of options 58                 58            
Shares issued upon exercise of options, shares           9,892                    
Shares issued upon exercise of common stock warrants 29                 29            
Shares issued upon exercise of common stock warrants, shares           145,379                    
Other comprehensive gain (loss) (11)                           (11)  
Net loss (104,682)                       (104,682)      
Ending balance at Mar. 31, 2022 26,063         $ 0       438,414     (412,279)   (72)  
Ending balance, shares at Mar. 31, 2022           4,924,688                    
Beginning balance at Dec. 31, 2021 (65,353) $ (218,331) $ 152,978 $ 152,978 $ (152,978) $ 0 $ 0 $ 0   242,305 $ 89,327 $ 152,978 (307,597) $ (307,597) (61) $ (61)
Beginning balance, shares at Dec. 31, 2021       7,695,112 (7,695,112) 2,850,876 250,898 2,599,978                
Issuance of PIPE shares $ 36,950                              
Shares issued upon exercise of options, shares 9,892                              
Net loss $ (130,356)                              
Ending balance at Jun. 30, 2022 24,808         $ 0       462,840     (437,953)   (79)  
Ending balance, shares at Jun. 30, 2022           6,476,566                    
Beginning balance at Mar. 31, 2022 26,063         $ 0       438,414     (412,279)   (72)  
Beginning balance, shares at Mar. 31, 2022           4,924,688                    
Issuance of common stock upon vesting of RSUs, shares           34,961                    
Stock-based compensation 5,006                 5,006            
Shares issued upon exercise of common stock warrants 41                 41            
Shares issued upon exercise of common stock warrants, shares           202,758                    
Other comprehensive gain (loss) (7)                           (7)  
Shares issued upon draw down of GEM agreement, shares           1,314,159                    
Shares issued upon draw down of GEM agreement 19,379         $ 0       19,379            
Net loss (25,674)                       (25,674)      
Ending balance at Jun. 30, 2022 $ 24,808         $ 0       $ 462,840     $ (437,953)   $ (79)  
Ending balance, shares at Jun. 30, 2022           6,476,566